Search clinical trials for: ARALAST Alpha1-Proteinase Inhibitor

Total 7825 results

Pfizer

Completed

PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants

Healthy Participants

United States
Hong Kong WD Pharmaceutical Co., Limited

Unknown

A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition

Anticoagulant
Jatupon Kongtharvonskul
Police General Hospital

Completed

Comparative Outcomes Between Foot Cast and Short Leg Cast in the Patients With Acute Closed Fracture of Proximal Fifth Metatarsal (Zone II)

Acute Closed Fracture of Proximal Fifth Metatarsal (Zone II)

Thailand
Hospital Mutua de Terrassa

Unknown

Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY) (SEDMAN)

Cardioembolic Stroke

Spain
Capital Medical University

Unknown

The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis

Cerebral Venous Thrombosis

China
Vanderbilt University

Terminated

Characterization of Brachial Arterial t-PA Release, Endothelial Function, Obesity and Inflammation (P1A3B)

Obesity

United States
University College, London

Unknown

The Coagulation Cascade in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease | IPF
Vanderbilt University

Withdrawn

Brachial Artery t-PA Release in Heart Transplant Recipients (P1A3C)

Heart Transplantation

United States
Boehringer Ingelheim

Withdrawn

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age

Venous Thromboembolism

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers

Healthy

Germany
University of Edinburgh

Completed

Interaction of Apelin and Angiotensin in the Systemic Circulation

Renin Angiotensin System

United Kingdom
Northwestern University

Suspended

Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

Covid19

United States
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Improvement of Pulmonary Insufficiency After Aortic Dissection With Sivelestat Sodium (IPIADSS)

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Aortic Dissection

China
Ain Shams University

Completed

Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection

Biochemical Markers ,NGAL,Cystatin c, Acute Kidneyinjury, Covid 19

Egypt
Boehringer Ingelheim

Completed

Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Atrial Fibrillation

Taiwan
Boehringer Ingelheim

Completed

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Venous Thromboembolism

Italy, Thailand, Russian Federation, Canada, Lithuania, Switzerland
Boehringer Ingelheim

Completed

A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin

Atrial Fibrillation

Japan
Fox Chase Cancer Center

Terminated

Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC)

Metastatic Renal Cell Carcinoma | RCC

United States
Qin Zhang

Recruiting

Ulinastatin Improves and Prevents Cardiac Dysfunction Induced by Cardiopulmonary Bypass

Pharmacological Action

China
Brigham and Women's Hospital

Completed

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Replication of the EINSTEIN-PE Anticoagulant Trial in Healthcare Claims Data

Pulmonary Embolism

United States
Bristol-Myers Squibb
Pfizer

Completed

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

NonValvular Atrial Fibrillation

Japan
Saud Al Babtain Cardiac Center

Completed

Apixaban in Patients With Left Ventricular Thrombus

Left Ventricular Thrombus

Saudi Arabia
University of South Florida
Bristol-Myers Squibb

Completed

Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation (AREST)

Stroke | Atrial Fibrillation | Transient Ischemic Attack

United States
Bristol-Myers Squibb
Pfizer

Completed

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Anticoagulation

India
Swiss Paraplegic Centre Nottwil

Withdrawn

Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury (rivaroxaban)

Thromboembolism | Spinal Cord Injuries

Switzerland
Ottawa Hospital Research Institute
Bristol-Myers Squibb; Canadian Institutes of Health Research (CIHR)

Completed

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients (AVERT)

Cancer | Venous Thromboembolism

Canada
Bristol-Myers Squibb

Withdrawn

Early Post-marketing Study of Eliquis (Apixaban)

Non-valvular Atrial Fibrillation (NVAF)

Mexico
University of North Carolina, Chapel Hill

Completed

A Prospective Pharmacodynamic Study of Rivaroxaban

Blood Clot

United States
Astellas Pharma Inc

Completed

Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities

Venous Thromboembolism

Japan
Assistance Publique - Hôpitaux de Paris
Action Research Group; Bristol-Meyers Squibb & Pfizer

Completed

Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis (ATLANTIS)

Symptomatic Aortic Stenosis | Eligible for Transcatheter Aortic Valve Replacement

France, Germany, Italy, Spain
Brigham and Women's Hospital

Completed

Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data

Atrial Fibrillation

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Effect of Rivaroxaban in Sickle Cell Disease

Sickle Cell Anemia | Sickle Cell-Beta0-Thalassemia

United States
Second Affiliated Hospital, School of Medicine,...

Unknown

A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders | Foot Ankle Injuries

China
Turku University Hospital
Helsinki University Central Hospital

Completed

NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers (EdoRot)

Blood Coagulation Disorder

Finland
Hospital Universitari Vall d'Hebron Research Institute

Completed

Rivaroxaban for Patients With Antiphospholipid Syndrome

Antiphospholipid Syndrome

Spain
Bristol-Myers Squibb

Completed

Eliquis Regulatory Post Marketing Surveillance

NonValvular Atrial Fibrillation

Korea, Republic of
Bristol-Myers Squibb
Pfizer; Duke Clinical Research Institute

Terminated

Phase III Acute Coronary Syndrome (APPRAISE-2)

Acute Coronary Syndrome

Argentina, China, India, Japan, Korea, Republic of, Mexico, Poland, South Africa, Sweden, United States, Chile, Spain, United Kingdom, Australia, Brazil, Colombia, Austria, Denmark, Germany, Belgium, Hungary, Israel, Peru, Romania, Russian... and more
University Hospital Inselspital, Berne
Bayer; Centre Hospitalier Universitaire Vaudois

Completed

Rivaroxaban in Bariatric Surgery

Prophylaxis of Venous Thromboembolism

Switzerland
Astellas Pharma Europe B.V.

Completed

Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects With Acute Coronary Syndromes (RUBY-1)

Acute Coronary Syndrome

Poland, Colombia, Germany, Korea, Republic of, South Africa, Czech Republic, Netherlands, Hungary, Russian Federation, Mexico, Romania, Argentina, Ukraine, Denmark, Slovakia, Belgium, India, Brazil, Australia, Canada, France
Bayer

Completed

BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status

Atrial Fibrillation

Japan
Bayer

No longer available

Aprotinin US Special Access Protocol

Postoperative Hemorrhage

United States
Astellas Pharma Inc

Completed

A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet

Healthy Volunteer | Pharmacokinetics of YM150

Japan
Soroka University Medical Center

Unknown

Effect of Intraoperative Aprotinin Administration on Post Cardiac Surgery Optic Nerve and Retinal Thickness.

Cardiac Surgery

Israel
Boehringer Ingelheim

Recruiting

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot (DaPaR)

Venous Thromboembolism

Spain, Germany, Netherlands, Czechia, Finland, Sweden
BioCryst Pharmaceuticals

Active, not recruiting

Berotralstat Treatment in Children With Hereditary Angioedema (APeX-P)

Hereditary Angioedema | Pediatric

Spain, Austria, Canada, France, Germany, Israel, Italy, Poland, Romania, United Kingdom
Boehringer Ingelheim

Terminated

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Venous Thromboembolism | Arthroplasty, Replacement

Austria
Enrique Ginzburg
Grifols Biologicals, LLC

Terminated

Antithrombin III in Infectious Disease Caused by COVID-19

Covid19 | Antithrombin III Deficiency

United States
Qian Gong

Unknown

Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)

Coronary Heart Disease

Search clinical trials for: ARALAST Alpha1-Proteinase Inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations